Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of acute pulmonary embolism: a propensity-matched analysis of 478 patients
30 April 2017 (08:30 - 18:00)
Organised by:
Abstract
About the speaker

Hospital de Santa Cruz, Carnaxide (Portugal)
51 More presentations in this session
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
30 April 2017
08:30 CET
